Mike is a pharmaceutical industry veteran with 22 years of experience in research, alliance and program management, business development, scientific diligence, contract management and business projects.
Mike began his career in medicinal chemistry at SmithKline Beecham (now GSK), delivering multiple candidate and pre-candidate molecules as a team and matrix leader. He then transitioned to its innovative Center of Excellence for External Drug Discovery where he helped to set strategy leading to the creation of complex alliances in the biotech space. Mike variably also served as the alliance leader or joint steering committee member for established alliances and focused his efforts primarily at the interface of discovery and development. Subsequently, he held a similar role in GSK’s ophthalmology research unit before joining Johnson & Johnson Diabetes, leading multi-disciplinary teams in the evaluation and execution of business relationships.
Mike is a strategic and scientific thinker, highly skilled at drug discovery, preclinical development, and managing teams and business relationships, and has led programs across therapy areas including in oncology, cardiovascular disease, inflammatory disorders, infectious diseases and ophthalmology.